Walder Wyss advised Alentis Therapeutics on the deal. Honigman advised Catalio Capital Management. Alentis Therapeutics raised $181.4 million in Series D financing, supported by a syndicate...
Alentis Therapeutics’ $181.4 Million Series D Financing Round
Elucid Bioimaging Inc.’s $80 Million Series C Funding Round
Honigman represented Elucid Bioimaging Inc. in the transaction, and Latham and Watkins represented Elevage Medical Technologies. Elucid Bioimaging Inc. announced it has raised $80 million in Series C...